EBI Life Sciences, Inc. — Form D/A
EBI Life Sciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2012-05-30. The offering totals $27K, of which $27K was reported sold. Industry: Other Technology.
Offering
- Filed: 2012-05-30
- Form: D/A
- Accession: 0001140361-12-027794
- Industry: Other Technology
- Exemptions: 06
- Total offering: $27K
- Amount sold: $27K
- Minimum investment: $140
- Investors: 7
- Date of first sale: 2012-03-02
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-175100
Issuer
- Name: EBI Life Sciences, Inc.
- CIK: 0001544177
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 43 THORNDIKE STREET, CAMBRIDGE, MA, 02141
- Phone: 617-758-0300
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Timothy J Barberich | Director | Woburn, MA |
| Joshua P Funder | Director | Melbourne VIC, C3 |
| Frank P Gentile | Director | Boston, MA |
| Anthony A McKinney | Director | Cambridge, MA |
| Campbell P Murray | Director | Cambridge, MA |
| Paul P Weiss | Director | Madison, WI |
| Franklin P Bymaster | Executive Officer | Brownsburg, IN |
| Anthony A McKinney | Executive Officer | Cambridge, MA |
| Thomas A Shea | Executive Officer | Cambridge, MA |
| Pierre J Tran | Executive Officer | Cambridge, MA |
| Andrew P Baker | Director | Melbourne VIC, C3 |
Other filings by this issuer (1)
More